Celltrion Healthcare, Stock Price +0.81% at This Time... 231,297 Shares Net Bought by Individuals in the Last 5 Days
As of 10:30 AM on the 15th, Celltrion Healthcare is trading at 100,000 KRW, up 0.81% from the previous day. The trading volume is 278,191 shares, which is about 34.26% of the previous day's volume. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
On September 11, Shin Jae-hoon, a researcher at Hanwha Investment & Securities, stated, "We maintain our top pick opinion within the industry. Although the company's expected 2020 performance has not yet been reflected, if it is incorporated in the third quarter earnings estimates, a valuation upgrade in terms of earnings and growth potential is possible. Furthermore, if sales of Remsima SC in the European region explode in the fourth quarter, the success potential in the larger North American market will be reflected, and the corporate value is expected to level up." He set the target price for Celltrion Healthcare at 150,000 KRW.
Over the past five days, individual investors have net purchased 231,297 shares of Celltrion Healthcare, while foreigners and institutions have net sold 136,562 shares and 109,691 shares, respectively.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 40s Who Kept Girlfriend's Body for a Year After Murder Sentenced to 30 Years in Prison Again on Appeal
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
